Evidence map›Paper›PMID 26341586›Full record

ReviewTransfusion medicine reviews2015

Platelet MicroRNAs: An Overview.

Neetu Dahiya, Tewarit Sarachana, Long Vu, Kevin G Becker, William H Wood, Yongqing Zhang, Chintamani D Atreya

Open access · bronzeAbstract readReview
In one paragraph

Review in Transfusion medicine reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Thromborepair: the tissue repair partner to thromboinflammation.Blood vessels, thrombosis & hemostasis · 2026
    Review
  2. Article
  3. Article
  4. The platelet storage lesion, what are we working for?Journal of clinical laboratory analysis · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Primary Thrombophilia XVI: A Look at the Genotype of the Sticky Platelet Syndrome Phenotype.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Neetu DahiyaSection of Cell Biology, Laboratory of Cellular Hematology, Division of Hematology Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Tewarit SarachanaDepartment of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.
Long VuSection of Cell Biology, Laboratory of Cellular Hematology, Division of Hematology Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Kevin G BeckerLaboratory of Genetics, National Institute on Aging, Baltimore, MD.
William H WoodLaboratory of Genetics, National Institute on Aging, Baltimore, MD.
Yongqing ZhangLaboratory of Genetics, National Institute on Aging, Baltimore, MD.
Chintamani D AtreyaSection of Cell Biology, Laboratory of Cellular Hematology, Division of Hematology Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD. Electronic address: chintamani.atreya@fda.hhs.gov.
National Institute on Aging · USCenter for Biologics Evaluation and Research · USChulalongkorn University · THUnited States Food and Drug Administration · US

Funding

Analysis of complex biological systems by microarray based gene expressionZICAG000616 · NIA · NATIONAL INSTITUTE ON AGING · PI DE, SUPRIYO · 2009 to 2025
$15.5M
Intramural NIH HHS Z99 AG999999
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are short ~22-nucleotide noncoding RNA that have been found to influence the expression of many genes and cellular processes by either repressing translation or degrading messenger RNA transcripts. Platelet miRNA expression has been shown to be perturbed during ex vivo storage of platelets and in platelet-associated disorders. Although bioinformatics-based miRNA target predictions have been established, direct experimental validation of the role of miRNAs in platelet biology has been rather slow. Target prediction studies are, nonetheless, valuable in directing the design of appropriate experiments to test specific miRNA:messenger RNA interactions relevant to the underlying mechanisms of platelet function in general and in disease as well as in ex vivo storage-associated "storage lesions," a collective term used to include physiologic, biochemical, and morphologic changes that occur in stored platelets. This brief review will focus on emerging human platelet miRNA studies to emphasize their potential role relevant to transfusion medicine field in terms of regulating platelet signaling pathways, markers of platelet associated disorders, and remote impactors of gene expression (intercellular biomodulators) as well as potential platelet quality markers of storage and pathogen reduction treatments.

Indexed as

AnimalsBlood Platelet DisordersBlood PlateletsBlood PreservationGene Expression RegulationGenetic MarkersHumansMicroRNAsSignal TransductionGenetic MarkersMicroRNAsBlood disordersMicroRNAPlateletsSignaling pathways

Identifiers

PMID26341586
PMCPMC5903434
OpenAlexW1702220632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.